Wednesday, October 11, 2017| Alcon, Alcon, Carl Zeiss Meditec, Clareon AutonoMe, Intraocular lens, IOL, IOLs, Johnson & Johnson Vision Care, OPMI Lumera

EyewireTV — Breaking News Live from the ESCRS Meeting in Lisbon

In this week’s EyewireTV, Alcon introduces the Clareon hydrophobic acrylic IOL and AutonoMe preloaded automated IOL delivery system; and Johnson & Johnson Vision announces the launch of its iDesign 2.0 refractive studio system. Also, Carl Zeiss Meditec releases the AT LARA extended-depth-of-focus IOL and the OPMI LUMERA 700 microscope.

Watch Video

Tuesday, October 03, 2017| Case Report

EyewireTV - Solving Complicated Surgical Cases

In this week’s EyewireTV, leading ophthalmologists share complicated or unique surgical cases they encountered, the options that were considered, and ultimately, how the cases were handled.

Watch Video

Wednesday, September 20, 2017| Johnson & Johnson Vision Care

EyewireTV - J&J Acquires Sightbox; Phase 3 GA Drug Candidate Fails

In this week’s EyewireTV, Johnson & Johnson Vision acquires Sightbox, an online membership-based subscription service for contact lens wearers; and Genentech’s lampalizumab, a drug candidate being evaluated for the treatment of geographic atrophy due to AMD, fails a phase 3 trial. Also, Carl Zeiss Meditec announces the US launch of its next-generation, ultra-widefield fundus imaging system, the CLARUS 500.

Watch Video

Wednesday, September 13, 2017

EyewireTV — Students Provide Reaction from ME Live Meeting in Nashville

In this week’s EyewireTV, residents and trainees provide their reaction to being invited to MillennialEYE Live in Nashville and discuss the pearls they have taken away from the meeting.

Watch Video

Wednesday, September 06, 2017| Acquisitions, Mergers, Alcon, Alcon, CyPass Micro-Stent, Johnson & Johnson Vision Care, Medicare, Novartis, TearScience

EyewireTV - J&J Completes TearScience acquisition; New Novartis CEO

In this week’s EyewireTV, Johnson & Johnson Vision completes its acquisition of privately held TearScience; and Novartis CEO Joseph Jimenez announces he is stepping down from his role in January and will be replaced by Vasant Narasimhan, the company's current global head of drug development and chief medical officer. Also, Alcon announces that the Unique Procedure Code for the CyPass Micro-Stent has become effective, paving the way for Medicare reimbursement.

Watch Video

Wednesday, August 30, 2017| AcuFocus, Clinical Trials, FDA Approval/Clearance, Intraocular lens, IOL, IOLs, prosthetic vision systems, Second Sight Medical Products, stem cell therapy

EyewireTV — Stem Cell Overhaul; New Visual Prothesis System

In this week’s EyewireTV, the FDA announces plans to crack down on stem cell clinics marketing and selling unapproved and potentially harmful therapies; and Second Sight Medical Products receives conditional approval from the FDA to begin the first human clinical trial of the Orion Cortical Visual Prosthesis System. Also, AcuFocus announces the publication of a European post-market study of the IC-8 small-aperture IOL.

Watch Video
Load More